Nuzenio

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 10 publisher sources 100/100 entity strength

Latest news

‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culprit - BioPharma DiveBioPharma Dive · Fri, 07 Aug 2026 15:02:34 GMT Arrowhead Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript - GuruFocusGuruFocus · Thu, 06 Aug 2026 23:37:58 GMT Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeatMarketBeat · Thu, 06 Aug 2026 19:12:25 GMT Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Forecasts - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 22:07:42 GMT Arrowhead buys PRV for $215M; Twist hopes to raise $300M in public offering - Endpoints NewsEndpoints News · Wed, 05 Aug 2026 14:28:00 GMT ARWR: Acquires PRV for sNDA Submission for Plozasiran in sHTG - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 13:38:00 GMT Arrowhead acquires FDA priority review voucher for plozasiran's severe hypertriglyceridemia expansion - AllSciAllSci · Wed, 05 Aug 2026 09:58:01 GMT Arrowhead Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $110.2, Implies 23% Upside - TradingViewTradingView · Wed, 05 Aug 2026 09:20:04 GMT

Timeline

Fri, 07 Aug 2026 15:02:34 GMT‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culprit - BioPharma Dive

Thu, 06 Aug 2026 23:37:58 GMTArrowhead Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Thu, 06 Aug 2026 19:12:25 GMTArrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat

Wed, 05 Aug 2026 22:07:42 GMTArrowhead Pharmaceuticals, Inc. (ARWR) Stock Forecasts - Yahoo Finance

Wed, 05 Aug 2026 14:28:00 GMTArrowhead buys PRV for $215M; Twist hopes to raise $300M in public offering - Endpoints News

Wed, 05 Aug 2026 13:38:00 GMTARWR: Acquires PRV for sNDA Submission for Plozasiran in sHTG - Yahoo Finance

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

ARWR20 live mentions Inc17 live mentions Yahoo Finance Arrowhead5 live mentions Yahoo Finance Yahoo5 live mentions Finance5 live mentions Arrowhead Pharmaceuticals Inc4 live mentions NASDAQ4 live mentions Plozasiran4 live mentions Earnings Call Highlights4 live mentions Could Change Following4 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Arrowhead Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.